Bipolar Depression: Diagnostic Dilemmas to Innovative Treatments

Bipolar disorder (BD) is a severe, lifelong disorder associated with high rates of nonrecovery, chronicity, and premature mortality. The actionable opportunity for reducing the morbidity and mortality of BD is to address current unmet needs.

Click here to read the supplement and earn 1 AMA Category 1 Credit ^TM by learning about these unmet needs, and recent advances and novel strategies for management of depression in BD. 

---

Educational Objectives

• Discuss the prevalence of bipolar disorder in different psychiatric patients.
• Describe the different symptoms that occur in children, adolescents, and adults.
• Use the evidence base, including FDA approval for different treatments, to inform therapy for bipolar depression.
• Provide details to ensure that physicians consider the potential metabolic profile of antipsychotics when choosing agents.

Click here to read the supplement. 

 

Bipolar disorder (BD) is a severe, lifelong disorder associated with high rates of nonrecovery, chronicity, and premature mortality. The actionable opportunity for reducing the morbidity and mortality of BD is to address current unmet needs.

Click here to read the supplement and earn 1 AMA Category 1 Credit ^TM by learning about these unmet needs, and recent advances and novel strategies for management of depression in BD. 

---

Educational Objectives

• Discuss the prevalence of bipolar disorder in different psychiatric patients.
• Describe the different symptoms that occur in children, adolescents, and adults.
• Use the evidence base, including FDA approval for different treatments, to inform therapy for bipolar depression.
• Provide details to ensure that physicians consider the potential metabolic profile of antipsychotics when choosing agents.

Click here to read the supplement. 

 

Bipolar disorder (BD) is a severe, lifelong disorder associated with high rates of nonrecovery, chronicity, and premature mortality. The actionable opportunity for reducing the morbidity and mortality of BD is to address current unmet needs.

Click here to read the supplement and earn 1 AMA Category 1 Credit ^TM by learning about these unmet needs, and recent advances and novel strategies for management of depression in BD. 

---

Educational Objectives

• Discuss the prevalence of bipolar disorder in different psychiatric patients.
• Describe the different symptoms that occur in children, adolescents, and adults.
• Use the evidence base, including FDA approval for different treatments, to inform therapy for bipolar depression.
• Provide details to ensure that physicians consider the potential metabolic profile of antipsychotics when choosing agents.

Click here to read the supplement.